Mercer Global Advisors
EVH icon

Mercer Global Advisors’s Evolent Health EVH Stock Holding History

Mercer Global Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Buy
+35,848
New +$137K ﹤0.01% 3260
2020
Q1 		– Sell
-10,860
Closed -$98K – 1144
2019
Q4 		$98K Sell
10,860
-6,780
-38% -$55.1K ﹤0.01% 1124
2019
Q3 		$126K Buy
17,640
+7,148
+68% +$51.3K ﹤0.01% 1067
2019
Q2 		$83K Sell
10,492
-2,405
-19% -$28.5K ﹤0.01% 1108
2019
Q1 		$162K Buy
+12,897
New +$204K 0.01% 999

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Mercer Global Advisors's EVH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Evolent Health (EVH) in Q2 2026: 35,848 shares worth $194K. The stake represents ﹤0.01% of the portfolio and ranks #3260 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in EVH as recently as Q4 2019.

Mercer Global Advisors first reported a position in EVH in Q1 2019 and has held it in 5 quarters since. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Mercer Global Advisors held 35,848 shares of Evolent Health worth $194K as of Q2 2026.
  • Evolent Health was a new Mercer Global Advisors position in Q2 2026.
  • Evolent Health made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3260 holding.
  • Mercer Global Advisors first reported a position in Evolent Health in Q1 2019 and has held it in 5 quarters since.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.